FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3206276739> ?p ?o ?g. }

• W3206276739 endingPage "34" @default.
• W3206276739 startingPage "28" @default.
• W3206276739 abstract "The objective was to compare the long-term clinical, radiological, and cognitive outcomes in children with single-lesion neurocysticercosis who received 7 or 28 days of albendazole therapy.This observational study conducted over 1 year included (1) consecutive children with single-lesion neurocysticercosis who received 7 or 28 days of albendazole therapy in the acute state and (2) completed follow-up for at least 5 years. Seizure recurrence, resolution of lesions, cognition (Malin's Intelligence Scale for Indian Children), behavior, and school performance (National Initiative for Children Healthcare Quality Vanderbilt Assessment Scale) were assessed.Group A (albendazole for 7 days) comprised 55 children, and group B (albendazole for 28 days) included 48 children. The mean age at the time of diagnosis of neurocysticercosis was 6.6 ± 1.8 years; the mean age at the time of assessment for the study was 13.2 ± 1.2 years. Focal-onset seizures were the most common clinical presentation (58.3%). The majority of lesions were ring-shaped (92.3%) or colloidal (58.2%), with perilesional edema (89.3%). In the long-term follow-up, radiological resolution of the lesions was comparable in both groups. Complete resolution was seen in 52.7% receiving 7 days and 54.2% receiving 28 days albendazole. Seizures recurred in 20% receiving 7 days and 20.8% receiving 28 days albendazole. Overall, a low intelligence quotient (IQ < 70) was seen in 55.3% cases, somewhat problematic school performance in 12%, and behavioral abnormalities were present in 20% of the cases. The results were comparable between the 2 groups.Seizure control, radiological resolution of lesion, school performance, cognitive and behavioral outcomes in the long term are comparable in children with single-lesion neurocysticercosis who have received albendazole cysticidal therapy for 7 days and 28 days. Recurrence of seizure is seen with both regimens in the long term, necessitating regular follow-up and discussion regarding the risk of recurrence before a withdrawal of anticonvulsant therapy." @default.
• W3206276739 created "2021-10-25" @default.
• W3206276739 creator A5005660856 @default.
• W3206276739 creator A5034291730 @default.
• W3206276739 creator A5051814066 @default.
• W3206276739 creator A5069722483 @default.
• W3206276739 creator A5081390575 @default.
• W3206276739 date "2021-10-12" @default.
• W3206276739 modified "2023-09-27" @default.
• W3206276739 title "Comparison of Long-Term Outcomes Between 7 Days and 28 Days Albendazole Monotherapy in the Treatment of Single-Lesion Neurocysticercosis in Children" @default.
• W3206276739 cites W1977164656 @default.
• W3206276739 cites W1987702646 @default.
• W3206276739 cites W2035905454 @default.
• W3206276739 cites W2041340410 @default.
• W3206276739 cites W2048525546 @default.
• W3206276739 cites W2069691118 @default.
• W3206276739 cites W2090934264 @default.
• W3206276739 cites W2095311933 @default.
• W3206276739 cites W2098111569 @default.
• W3206276739 cites W2115811583 @default.
• W3206276739 cites W2141060238 @default.
• W3206276739 cites W2294598102 @default.
• W3206276739 cites W2315095414 @default.
• W3206276739 cites W2765311784 @default.
• W3206276739 cites W2800481375 @default.
• W3206276739 cites W3019721824 @default.
• W3206276739 cites W4252534070 @default.
• W3206276739 cites W4256334189 @default.
• W3206276739 doi "https://doi.org/10.1177/08830738211035864" @default.
• W3206276739 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34641721" @default.
• W3206276739 hasPublicationYear "2021" @default.
• W3206276739 type Work @default.
• W3206276739 sameAs 3206276739 @default.
• W3206276739 citedByCount "3" @default.
• W3206276739 countsByYear W32062767392022 @default.
• W3206276739 crossrefType "journal-article" @default.
• W3206276739 hasAuthorship W3206276739A5005660856 @default.
• W3206276739 hasAuthorship W3206276739A5034291730 @default.
• W3206276739 hasAuthorship W3206276739A5051814066 @default.
• W3206276739 hasAuthorship W3206276739A5069722483 @default.
• W3206276739 hasAuthorship W3206276739A5081390575 @default.
• W3206276739 hasConcept C141071460 @default.
• W3206276739 hasConcept C187212893 @default.
• W3206276739 hasConcept C2777065887 @default.
• W3206276739 hasConcept C2780449708 @default.
• W3206276739 hasConcept C2781156865 @default.
• W3206276739 hasConcept C71924100 @default.
• W3206276739 hasConceptScore W3206276739C141071460 @default.
• W3206276739 hasConceptScore W3206276739C187212893 @default.
• W3206276739 hasConceptScore W3206276739C2777065887 @default.
• W3206276739 hasConceptScore W3206276739C2780449708 @default.
• W3206276739 hasConceptScore W3206276739C2781156865 @default.
• W3206276739 hasConceptScore W3206276739C71924100 @default.
• W3206276739 hasIssue "1" @default.
• W3206276739 hasLocation W32062767391 @default.
• W3206276739 hasLocation W32062767392 @default.
• W3206276739 hasOpenAccess W3206276739 @default.
• W3206276739 hasPrimaryLocation W32062767391 @default.
• W3206276739 hasRelatedWork W1496221933 @default.
• W3206276739 hasRelatedWork W1968007595 @default.
• W3206276739 hasRelatedWork W2001235835 @default.
• W3206276739 hasRelatedWork W2042781450 @default.
• W3206276739 hasRelatedWork W2081604875 @default.
• W3206276739 hasRelatedWork W2085530451 @default.
• W3206276739 hasRelatedWork W2167403222 @default.
• W3206276739 hasRelatedWork W2327456423 @default.
• W3206276739 hasRelatedWork W2343392751 @default.
• W3206276739 hasRelatedWork W2616628834 @default.
• W3206276739 hasVolume "37" @default.
• W3206276739 isParatext "false" @default.
• W3206276739 isRetracted "false" @default.
• W3206276739 magId "3206276739" @default.
• W3206276739 workType "article" @default.